Cargando…
Co-occurrence CDK4/6 amplification serves as biomarkers of de novo EGFR TKI resistance in sensitizing EGFR mutation non-small cell lung cancer
Despite the development of predictive biomarkers to shape treatment paradigms and outcomes, de novo EGFR TKI resistance advanced non-small cell lung cancer (NSCLC) remains an issue of concern. We explored clinical factors in 332 advanced NSCLC who received EGFR TKI and molecular characteristics thro...
Autores principales: | Sitthideatphaiboon, Piyada, Teerapakpinyo, Chinachote, Korphaisarn, Krittiya, Leelayuwatanakul, Nophol, Pornpatrananrak, Nopporn, Poungvarin, Naravat, Chantranuwat, Poonchavist, Shuangshoti, Shanop, Aporntewan, Chatchawit, Chintanapakdee, Wariya, Sriuranpong, Virote, Vinayanuwattikun, Chanida |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8828869/ https://www.ncbi.nlm.nih.gov/pubmed/35140316 http://dx.doi.org/10.1038/s41598-022-06239-y |
Ejemplares similares
-
Prognostic factors in completely resected lymph-node-negative pulmonary adenocarcinoma
por: Pakvisal, Nussara, et al.
Publicado: (2022) -
Vimentin expression status is a potential biomarker for brain metastasis development in EGFR-mutant NSCLC patients
por: Teocharoen, Rattanawadee, et al.
Publicado: (2021) -
Development of ultra-short PCR assay to reveal BRAF V600 mutation status in Thai colorectal cancer tissues
por: Chat-Uthai, Nunthawut, et al.
Publicado: (2018) -
Differential expression of immune-regulatory proteins C5AR1, CLEC4A and NLRP3 on peripheral blood mononuclear cells in early-stage non-small cell lung cancer patients
por: Pakvisal, Nussara, et al.
Publicado: (2022) -
GCT-13. KRAS MUTATION IN PEDIATRIC INTRACRANIAL GERM CELL TUMORS
por: Khaiman, Chusana, et al.
Publicado: (2022)